Published in:
01-04-2017 | Case report
Capecitabine/temozolomide/yttrium-90
Hyperbilirubinemia: case report
Published in: Reactions Weekly | Issue 1/2017
Login to get accessExcerpt
Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* requires intervention to prevent permanent impairment or damage